( September 5, 2025, 4:15 PM EDT) -- WASHINGTON, D.C. — The Association for Accessible Medicines (AAM) tells the U.S. Supreme Court in an amicus curiae brief in support of MSN Pharmaceuticals and related entities (MSN) that the Federal Circuit U.S. Court of Appeals created a situation where medicine patent holders “will see a new strategy they can employ to fashion overbroad claims to delay generic competition” while skirting patent law requirements “that protect the public’s interests in ensuring that patents do not let inventors control more than they invented.”...